lindaelane wrote:My mother and maternal grandmother had dementia. I am 3/4. I know it is not certain, but I think the "4" was probably from grandmother/mother. (No dementia on father's side). ...
Anyway...my question...I know being female raises my risk but being educated lowers it. Does the 80ish onset for my female relatives say I may at least have some reduced risk until I'm older? (This presumes they were both 3/4....I want to take that presumption and go from there.)...
Hi lindaelane, what a great question!
Many of us have one or two copies of ApoE 4 (which is true for about 20-25% of the population with European ancestry), and many of us also have a family history of some kid of dementia. It's important to remember that what we sometimes assumed was Alzheimer's disease may well have been vascular dementia, linked to cardiac disease, high blood pressure and strokes, or other dementias such as Parkinson's with dementia or Lewy Body dementia. Given how little was known about the risk of high blood pressure in most of the 20th century, and how little was known about coronary artery disease in women, it's possible your mother and grandmother had risk factors you don't share and are unlikely to develop.
Here's a meta-analysis of four large studies (three of them population-based, following people for decades, one drawn from memory care center referrals). Their prediction of risk of either Mild Cognitive Impairment (MCI) or dementia to the age of 85 for people currently 60 and 75 is encouraging:
The Generation Study elected to disclose the following “lifetime” risks of MCI or dementia to its potential participants: 30%–55% for individuals with APOE-e4/e4; 20%–25% for individuals with APOE-e3/e4 and -e2/e4 (with a note that risk might be lower for those with APOE-e2/e4); and 10%–15% for individuals with APOE-e3/e3, -e3/e2, and -e2/e2 (with a note that risk might be lower for those with APOE-e2/e3 and -e2/e2). These values are consistent with our findings, but use round numbers for intelligibility, and broader ranges to reflect statistical and other sources of uncertainty. The regression models are insufficiently precise for “personalized medicine” incidence estimates based on sex, education, or other factors, but they do allow for qualitative adjustments to overall stratified risk estimates.
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts